SC
TNGX icon

Stempoint Capital’s Tango Therapeutics TNGX Stock Holding History

Stempoint Capital’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.2M Buy
+200,919
New +$2.8M 0.8% 38
2025
Q4 		– Sell
-245,378
Closed -$2.06M – 112
2025
Q3 		$2.06M Buy
245,378
+36,578
+18% +$248K 0.41% 49
2025
Q2 		$1.07M Buy
+208,800
New +$516K 0.34% 44

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Stempoint Capital's TNGX Position: Q1 2026 in Review

Stempoint Capital opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 200,919 shares worth $4.2M. The stake represents 0.8% of the portfolio and ranks #38 among its holdings. This is a return to the name: Stempoint Capital previously reported a position in TNGX as recently as Q3 2025.

Stempoint Capital first reported a position in TNGX in Q2 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Stempoint Capital held 200,919 shares of Tango Therapeutics worth $4.2M as of Q1 2026.
  • Tango Therapeutics was a new Stempoint Capital position in Q1 2026.
  • Tango Therapeutics made up 0.8% of Stempoint Capital's portfolio in Q1 2026, its #38 holding.
  • Stempoint Capital first reported a position in Tango Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.